Submit a New Drug Application for at least one product candidate
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 15 Nov 2023
- Due
- 30 Jun 2024
- Delivered
- August 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“potential submission of an NDA for at least one product candidate in mid-2024”
What we found
Evidence strength A What the grades mean
The company committed to a mid-2024 NDA submission but reported submitting the NDA for LNZ100 in August 2024, which is after the mid-2024 deadline.
-
A LENZ Therapeutics, Inc. 10-Q filed 2024-08-14
“we selected LNZ100 as our lead product candidate, for which we submitted a New Drug Application (“NDA”) to FDA in August 2024” ✓ confirmed on the page
Market reaction: the shares moved -4.1% against the S&P 500 over the three sessions around the disclosure (13 Aug 2024 to 16 Aug 2024). What this measures
Checked 2 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory submission
- Indicative materiality
- High rules
- Action
- Submit
- Deliverable
- New Drug Application
- In the company’s control
- High
- Specificity
- Medium
- Conditional
- Yes: successful completion of the ongoing Phase 3 trials
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you LENZ Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-LENZ-003356 · Corrections policy